the framework of the ITACARE project, a cooperative investigation cond
ucted on the data from the Italian population-based cancer registries,
survival of patients with childhood malignant neoplasms was studied.
The study included 1,768 cases diagnosed at age 0-14 plus 29 osteosarc
oma cases diagnosed at age 15-19. Cases were collected over the period
1978-1989, or more limited periods for some participating registries.
A total of 1,138 cases were from the Childhood Cancer Registry of Pie
dmont and 659 from the registries operating in the provinces of Varese
, Parma, Modena, Forli and Ravenna, Florence, Latina, Ragusa and in th
e cities of Geneva and Torino (the last contributed only for bone neop
lasm diagnosed at age 15-19). Overall 5-year survival was 54% for mali
gnancies diagnosed in 1978-1981, 60% for the period 1982-1985, and 69%
for the period 1986-1989. The range among registries of 5-year surviv
al for cases diagnosed in 1986-1989 was 55-78%. Most diagnostic catego
ries presented an improved prognosis for the cases diagnosed more rece
ntly. For cases diagnosed in 1986-1989, 5-year survival was: 74% for a
cute lymphatic leukaemia, 40% for acute non-lymphatic leukaemia, 65% f
or central nervous system neoplasms (76% for astrocytoma, 75% for epen
dymoma and 85% for medulloblastoma), 66% for osteosarcoma, 55% for Ewi
ng's sarcoma, 87% for Hodgkin's disease, 64% for non-Hodgkin's lymphom
a, 74% for rhabdomyosarcoma, 64% for neuroblastoma, 78% for nephroblas
toma and 100% for retinoblastoma. Italian survival was similar to that
observed in other population-based surveys in the UK and USA.